UCB (STU:UNC) Interest Expense: €-92 Mil (TTM As of Dec. 2025)


STU:UNC UCB SA STU:UNC
91 GF Score
Price €237.30
GF Value €211.34
Valuation Modestly Overvalued
View Full Analysis

What is UCB Interest Expense?

UCB STU:UNC -4.89% 91 Interest Expense is €-92 Mil as of Dec. 2025. GuruFocus rates STU:UNC with a GF Score™ of 91/100 and a GF Value™ of €211.34 (Modestly Overvalued).

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. UCB's interest expense for the six months ended in Dec. 2025 was € -49 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was €-92 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. UCB's Operating Income for the six months ended in Dec. 2025 was € 1,284 Mil. UCB's Interest Expense for the six months ended in Dec. 2025 was € -49 Mil. UCB's Interest Coverage for the quarter that ended in Dec. 2025 was 26.20. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

UCB  (STU:UNC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

UCB's Interest Expense for the six months ended in Dec. 2025 was €-49 Mil. Its Operating Income for the six months ended in Dec. 2025 was €1,284 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was €2,183 Mil.

UCB's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*1284/-49
=26.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

UCB Interest Expense Historical Data

* Premium members only.

The historical data trend for UCB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UCB Interest Expense Chart

UCB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -45.00 -71.00 -144.00 -159.00 -128.00

UCB Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -81.00 -64.00 -76.00 -43.00 -49.00
STU:UNC
91GF Score
UCB SA STU:UNC
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UCB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-92 Mil mean?
UCB (STU:UNC) has a Interest Expense of €-92 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on UCB and its competitors.
Is UCB's Interest Expense too high?
UCB's current Interest Expense is €-92 Mil. Overall, UCB has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does UCB's Interest Expense compare to VRTX and REGN?
UCB's Interest Expense of €-92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on UCB and its competitors. UCB's current Interest Expense is €-92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UCB stock overvalued right now?
Based on GuruFocus' analysis, UCB (STU:UNC) is currently considered Modestly Overvalued. The stock's GF Value™ is €211.34, compared to a current price of €237.30 — trading 12.3% above its estimated fair value. The current Interest Expense is €-92 Mil. UCB's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For UCB (STU:UNC), the current Interest Expense is €-92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UCB (STU:UNC) Overvalued in 2026?

Based on GuruFocus' analysis, UCB stock appears to be overvalued. The current stock price of €237.30 is trading 12.3% above its estimated GF Value™ of €211.34. GuruFocus considers UCB to be Modestly Overvalued.

Key valuation signals for STU:UNC:

  • Interest Expense: €-92 Mil
  • GF Value™: €211.34 vs. price of €237.30 (12.3% above fair value)
  • GF Score™: 91/100

No single metric tells the full story. See the STU:UNC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UCB Business Description

Address Allee de la Recherche, 60, Brussels, BEL, B-1070
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome), and Kygevvi (rare mitochondrial disease).
91GF Score

Get the complete analysis for STU:UNC

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€237.30
Price
€211.34
GF Value